baber/WOPTO huggingface dataset:
Patent WO-2020092122-A1 (WO)
Title: Methods and systems for chemically strengthening lithium-containing glass
Inventor: HU HONGMEI
IPC: C03C3/097
Filed: 2019-10-24
Abstract: Methods and systems of strengthening lithium-containing glass-based substrates including contacting at least a portion of the lithium-containing glass-based substrates with a first salt bath comprising at least 2 wt.% lithium nitrate and at least one of potassium nitrate and sodium nitrate and contacting at least a portion of the lithium-containing glass-based substrates with a second salt bath comprising at least one of potassium nitrate and sodium nitrate. The methods further include that after contacting 3 m 2  of glass per kilogram of molten salt (3 m 2 /kg salt) to 13 m 2 /kg salt for the first salt bath, a surface compressive stress imparted to the glass articles by the contacting steps decreases by less than 30 MPa.
Patent WO-2021080592-A1 (WO)
Title: Printing image-independent print data based on pixel characteristics
Inventor: LARSON BRADLEY R
IPC: G06T1/00
Filed: 2019-10-24
Abstract: According to examples, an apparatus may include a processor that may access a window of pixels corresponding to print data. The print data may specify printing of a plurality of pixels based on an original document image and image-independent print data. The apparatus may identify a first pixel, from among the window of pixels, corresponding to the image-independent print data, determine a characteristic associated with the window of pixels, determine, based on the characteristic, that the image-independent print data is to specify printing of a second pixel from among the window of pixels. The apparatus may cause the image-independent print data to specify printing of the second pixel based on the determination that the image-independent print data is to specify printing of the second pixel.
Patent WO-2020101901-A1 (WO)
Inventor: NOVLAN THOMAS
IPC: H04W24/02
Filed: 2019-10-31
Abstract: The disclosed technology is generally directed towards optimization and control of wireless networks based on monitoring and/or analytics data received at a radio access network (RAN) controller device in a split RAN protocol architecture. The RAN controller device processes the monitoring / analytics data and provides control information and/or optimization data, which can be policy data, to a central unit device that can configure the wireless network based on the control information and/or optimization data. The technology can facilitate optimization and configuration of mobility procedures including handovers and secondary cell group changes, optimization of carrier aggregation and dual connectivity procedures based on multiple metrics, and can facilitate centralized optimization of topology and route selection for integrated access and backhaul nodes.
Patent WO-2020106507-A1 (WO)
Inventor: MERCURI MARC EDWARD
IPC: H04L29/06
Filed: 2019-11-13
Abstract: A computing device includes a communications interface that communicatively couples the computing device with a plurality of other computing devices that collectively maintain a blockchain. A storage machine holds a plurality of blocks comprising the blockchain, where a particular block of the plurality defines a smart contract. The smart contract includes: (i) a first access criterion granted to an entity for a digital asset, and (ii) one or more functions that, when an associated condition is satisfied, change the first access criterion to a second access criterion, the condition being satisfied when one or more variables have specific values. A logic machine is configured to receive a current value of a variable and determine that the current value satisfies the associated condition. A request is transmitted to the plurality of computing devices to update the first access criterion to the second access criterion.
Patent WO-2020131384-A1 (WO)
Title: Pose de dispositif médical implantable pour thérapie cardiaque
Inventor: DRAKE RONALD A
IPC: A61N1/368
Filed: 2019-12-04
Abstract: Diverses techniques consistent à faire avancer un dispositif médical implantable comprenant une électrode de perforation de tissu vers la région du triangle de Koch de l'oreillette droite ou à travers le sinus coronaire pour administrer une thérapie cardiaque au ventricule gauche ou détecter une activité électrique du ventricule gauche dans la région basale, la région septale, ou la région basale-septale du myocarde ventriculaire gauche du cœur d'un patient. L'électrode de perforation de tissu peut comprendre un matériau imageable. Le dispositif médical implantable peut comprendre un élément imageable composé d'un matériau imageable couplé à un boîtier ou à un fil du dispositif médical implantable. Des informations d'image représentant le cœur du patient et le matériau imageable peuvent être acquises à l'aide d'une imagerie bidimensionnelle. Des informations d'orientation représentant le dispositif médical implantable peuvent être générées sur la base des informations d'image acquises.
Patent WO-2020132347-A1 (WO)
Inventor: MILANI ALI ABDOLLAHZADEH
IPC: G10K11/178
Filed: 2019-12-19
Abstract: Adaptive noise cancellation systems and methods comprise a reference sensor operable to sense environmental noise and generate a corresponding reference signal, an error sensor operable to sense noise in a noise cancellation zone and generate a corresponding error signal, a noise cancellation filter operable to receive the reference signal and generate an anti-noise signal to cancel the environmental noise in the cancellation zone, an adaptation module operable to receive the reference signal and the error signal and adaptively adjust the anti-noise signal, and a transient activity detection module operable to receive the reference signal, detect a transient noise event and selectively disable the adaptation module during the detected transient noise event.
Patent WO-2021096542-A1 (WO)
Title: Formulated and/or co-formulated liposome compositions containing ido antagonist prodrugs useful in the treatment of cancer and methods thereof
Inventor: STOVER DAVID
IPC: A61P35/00
Filed: 2020-11-12
Abstract: Formulated and/or co-formulated liposomes comprising IDO prodrugs and methods of making the liposomes are disclosed herein. The IDO prodrug compositions comprise a drug moiety, a lipid moiety, and linkage unit that inhibit IDO-1. The IDO prodrugs can be formulated and/or co-formulated into a liposome to provide a method of treating cancer, immunological disorders, and other disease by utilizing a targeted drug delivery vehicle.
Patent WO-2020160065-A1 (WO)
Title: Utilisation d'applications à la demande permettant la génération de numéros virtuels destinés au remplissage automatique sécurisé de formulaires par une carte sans contact
Inventor: RULE JEFFREY
IPC: G06F21/44
Filed: 2020-01-29
Abstract: Une première application peut émettre en sortie une forme comprenant des champs de paiement. Un système d'exploitation (OS) peut recevoir, en provenance d'une carte sans contact, une adresse universelle (URL) comprenant des données chiffrées. Une seconde application reçue en provenance de l'URL par l'OS peut être exécutée. La seconde application peut transmettre les données chiffrées à un serveur d'authentification, le serveur d'authentification permettant de vérifier les données chiffrées. La seconde application peut recevoir, en provenance d'un serveur de numéro de compte virtuel, un numéro de compte virtuel, une date d'expiration associée au numéro de compte virtuel, et un CVV associé au numéro de compte virtuel. La seconde application peut fournir le numéro de compte virtuel, la date d'expiration et le CVV à un service de remplissage automatique de l'OS. Le service de remplissage automatique de l'OS peut remplir automatiquement le numéro de compte virtuel dans les champs de paiement de la première application.
Patent WO-2020160121-A1 (WO)
Title: Oligonucléotides et méthodes pour le traitement de la dégénérescence maculaire liée à l'âge
Inventor: NAAR ANDERS M
IPC: C12N15/113
Filed: 2020-01-29
Abstract: L'invention concerne des oligonucléotides, des compositions et des méthodes qui peuvent être utiles dans le traitement de la dégénérescence maculaire liée à l'âge (DMLA). Le traitement de la dégénérescence maculaire liée à l'âge (DMLA) peut impliquer l'inhibition d'un acide nucléique cible de miR-33. Par exemple, l'inhibition d'un acide nucléique cible de miR-33 peut être obtenue à l'aide d'oligonucléotides antisens ciblant un acide nucléique cible de miR-33, d'oligonucléotides interférents ciblant un acide nucléique cible de miR-33, ou des particules de VAA recombiné comprenant un vecteur codant pour un oligonucléotide antisens ou un oligonucléotide interférant ciblant un acide nucléique cible de miR-33.
Patent WO-2020160130-A1 (WO)
Title: Système et procédé d'enregistrement entre systèmes de coordonnées et navigation d'éléments sélectionnés
Inventor: SNYDER VICTOR D
IPC: A61B34/20
Filed: 2020-01-29
Abstract: L'invention concerne un système d'aide au guidage et à la mise en oeuvre d'une procédure sur un sujet. Le système peut suivre simultanément une pluralité d'éléments dans un espace de navigation ou de suivi. Chacun des éléments suivis peut être associé à diverses parties, telles que des parties dans une image. L'image peut être segmentée pour différencier et délimiter la partie pour permettre un temps sensiblement réel (par exemple un retard minimal ou nul entre un mouvement d'espace réel et une représentation d'image) d'une pluralité d'éléments dans un espace de navigation. Le système de navigation peut fonctionner ou recevoir des informations de suivi provenant d'une pluralité de systèmes de suivi, comprenant un premier système de suivi fonctionnant dans une première modalité de suivi (par exemple électromagnétique (EM)) et un second système d'exploitation fonctionnant dans une seconde modalité de suivi (par exemple, un suivi optique).
Patent WO-2020163145-A1 (WO)
Inventor: YANG YIMIN
IPC: A61F2/24
Filed: 2020-01-30
Abstract: La présente invention concerne un système de valvule prothétique cardiaque comprenant une valvule prothétique cardiaque ayant un côté flux d'entrée, et un côté flux de sortie. La valvule cardiaque comprend en outre une base au niveau du côté flux d'entrée, une pluralité de montants de commissure et des feuillets de valvule solidement fixés aux montants de commissure afin de permettre l'écoulement à travers la valvule cardiaque. Un élément antiboucle ayant une première portion sur le côté flux d'entrée de la valvule cardiaque et une seconde portion sur le côté flux de sortie de la valvule cardiaque. La seconde portion de l'élément antiboucle est disposée le long de chaque montant de commissure au niveau de la pointe de chaque montant de commissure, et disposée le long d'au moins un montant de commissure deux fois afin d'effectuer une boucle autour de tous les montants de commissure. L'élément antiboucle est constitué d'un matériau suffisamment souple afin d'être retiré des montants de commissure sans endommager la valvule cardiaque encore suffisamment rigide afin de conserver sa forme lorsqu'elle entre en contact avec les sutures.
Patent WO-2020163816-A1 (WO)
Inventor: TAIT BRADLEY
IPC: A61K31/473
Filed: 2020-02-07
Abstract: The present disclosure relates to quinolin-4-one and 4(1H)-cinnolinone compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into tissue cells.
Patent WO-2021167584-A1 (WO)
Title: Apparatus, system and method for providing self extracting grips for an end effector
Inventor: BOSBOOM JEROEN
IPC: B25J15/00
Filed: 2020-02-17
Abstract: An apparatus, system and method for a wedge clamp suitable to provide self extracting grips for an end effector suitable to hold semiconductor wafers, or other substrates such as rectangular panels. The apparatus, system and method may include two inner jaws at least mechanically associated with a robotic base; two outer arms associated with the inner jaws via at least one arms cam; and a plurality of wedge clamps. Each of the wedge clamps may comprise: a spring; a cam loaded on the spring; and a cam travel path into which the cam is slidably associated. A contraction of the inner jaws and a consequent arms camming of the outer arms applies pressure to a circumferential edge of the semiconductor wafer such that the circumferential edge depresses each of the cams along its respective cam travel path and against its respective one of the springs. The jaws close may synchronously about a center point of the substrate, thereby keeping it centered.
Patent WO-2020197672-A1 (WO)
Inventor: KORCHEV ANDRIY
IPC: C01B32/158
Filed: 2020-02-21
Abstract: Carbon nanostructures are used to prepare electrode compositions for lithium ion batteries. In one example, carbon nanostructures, fragments of carbon nanostructures and/or fractured carbon nanotubes are provided in an aqueous dispersion that can be used in the manufacture of silicon-containing anodes. The aqueous dispersion can further include another conductive carbon additive such as carbon black.
Patent WO-2020172587-A1 (WO)
Title: Monogenic or polygenic disease model organisms humanized with two or more genes
Inventor: HOPKINS CHRISTOPHER
IPC: A01K67/027
Filed: 2020-02-21
Abstract: The present disclosure provides transgenic non-human animal (e.g., nematode) systems for assessing heterologous polygenic or monogenic phenotypes, their variants and drug discovery. The transgenic non-human animals (e.g., nematodes) contain a first heterologous polypeptide coding sequence and a second heterologous polypeptide coding sequence (a plurality of heterologous polypeptide coding sequences), wherein the first and second heterologous polypeptide coding sequences are integrated into the host animal genome, and wherein expression of the first and second heterologous polypeptide coding sequence contribute to the heterologous phenotype. The plurality of heterologous polypeptide coding sequences are interrelated wherein their expression products, directly or indirectly, contribute or lead to an observable phenotype.
Patent WO-2021050102-A1 (WO)
Title: Methods of restoring lysosomal function of retinal pigment epithelial cells by activation of tfeb
Inventor: SINHA DEBASISH
IPC: A61K38/06
Filed: 2020-03-06
Abstract: A method of restoring lysosomal function of retinal pigment epithelial (RPE) cells and a method of preventing and/or treating age-related macular degeneration (AMD), Stargardt's macular retinal degeneration, neurodegenerative disease, or diabetic retinopathy in a subject are provided. The methods comprise administering (i) a nucleic acid encoding a polypeptide comprising a constitutively active form of transcription factor EB (TFEB) or (ii) the polypeptide to a subject in need thereof. Associated polypeptides, nucleic acids, vectors, and compositions thereof also are provided.
Patent WO-2020190609-A1 (WO)
Inventor: EVGIN LAURA
IPC: C12N15/63
Filed: 2020-03-12
Abstract: This document relates to methods and materials for treating cancer. For example, engineered viruses (e.g., oncolytic viruses) encoding one or more inhibitors of apolipoprotein B editing complex 3B (APOBEC3B) polypeptide activity or expression and methods for using such viruses as an oncolytic agent (e.g., to treat cancer) are provided. For example, one or more engineered oncolytic viruses encoding one or more inhibitors of APOBEC3B polypeptide activity or expression can be administered to a mammal having cancer to treat that mammal.
Patent WO-2020205398-A1 (WO)
Title: Amplifier efficiency tracking in digital envelope tracking system
Inventor: BELITZER ALEXANDER
IPC: H03F1/02
Filed: 2020-03-26
Abstract: Systems, methods, and circuitries are described for performing envelope tracking based on amplifier efficiency. In one example, a method for generating a tracking supply voltage for a power amplifier is described. The method includes: generating a plurality of supply voltages having a corresponding plurality of differing voltage levels; receiving a transmit signal indicative of a baseband transmit signal; generating a level select signal based on the transmit signal; in response to the level select signal, outputting a selected supply voltage of the plurality of supply voltages as the tracking supply voltage; determining a gain compression characteristic for one or more of the plurality of differing voltage levels; generating an adjustment signal based on the gain compression characteristics; and adjusting the tracking supply voltage based on the adjustment signal.
Patent WO-2020210348-A1 (WO)
Inventor: DEL REAL IBANEZ LUIS JAVIER
IPC: G08G1/16
Filed: 2020-04-08
Abstract: A method and system supported by a vehicle for reducing false positive intersection detection is provided. The method includes receiving roadside information from a roadside unit positioned along a route of the vehicle. The method includes determining a type of road condition based on the received roadside information. The method also includes determining when to output a road status signal including the type of road condition to at least one of a vehicle user interface or an autonomous vehicle controller supported by the vehicle based on the determined type of road condition. The road status signal causing the user interface to display a message to the driver or causing the autonomous vehicle controller to adjust a vehicle behavior based on the type of road condition.
Patent WO-2020214476-A1 (WO)
Inventor: LO SHUI YIN
IPC: C12Q1/6827
Filed: 2020-04-09
Abstract: A method for detection, treatment, and prevention of an inflamed internal organ, the method includes recording the distribution of body surface temperature with a passive imaging device; utilizing meridian theory of traditional Chinese medicine for identifying a hot region; identifying the body surface temperature at the hot area, the hot line, and the hot acupoint; correlating a hot body surface temperature with a specific internal ailment; administering a predetermined amount of solid water particle solution to the whole body and/or to the hot area, the hot line, and the hot acupoint of the body; administering a predetermined amount of solid water particle solution to the whole body and/or to, the hot line, and the hot acupoint of the meridian on the human body; determining the healing effects of the internal inflammation by calculating multiple body surface temperatures over a duration.
Patent WO-2020219719-A1 (WO)
Inventor: KRAMMER FLORIAN
IPC: C07F5/02
Filed: 2020-04-23
Abstract: Provided herein are antibodies that bind to neuraminidase (NA) of different strains of influenza B virus, host cells for producing such antibodies, and kits comprising such antibodies. Also provided herein are compositions comprising antibodies that bind to NA of different strains of influenza B virus and methods of using such antibodies to diagnose, prevent or treat influenza virus disease.
Patent WO-2021242247-A1 (WO)
Inventor: VENKATA MADHUSUDAN KINTHADA
IPC: H04W76/15
Filed: 2020-05-28
Abstract: En mode non autonome (NSA), lorsqu'il détecte un nombre seuil de défaillances de communication associées à un réseau d'accès radio (RAN), un équipement utilisateur (UE) réduit sa consommation d'énergie en se déconnectant sélectivement du RAN. En mode NSA, l'UE se connecte à un réseau central par l'intermédiaire d'un RAN 4G et d'un RAN 5G. L'UE surveille la connexion au RAN 5G relativement aux défaillances de communication, telles des défaillances d'un canal d'accès aléatoire (RACH), des défaillances d'une liaison radio (RLF) et autres. Lorsque le nombre de défaillances détectées est supérieur à un seuil, l'UE peut déterminer que la qualité de la connexion au RAN 5G est relativement peu avantageuse et peut interrompre la connexion au RAN 5G.
Patent WO-2020257500-A1 (WO)
Inventor: TALBERT JOSHUA
IPC: A61B1/045
Filed: 2020-06-18
Abstract: Driving an emitter to emit pulses of electromagnetic radiation according to a jitter specification in a hyperspectral, fluorescence, and laser mapping imaging system is described. A system includes an emitter for emitting pulses of electromagnetic radiation and an image sensor comprising a pixel array for sensing reflected electromagnetic radiation. The system includes a driver for driving emissions by the emitter according to a jitter specification. The system is h that at least a portion of the pulses of electromagnetic radiation emitted by the emitter comprises one or more of a hyperspectral emission, a fluorescence emission, and/or a laser mapping pattern.
Patent WO-2020257512-A1 (WO)
Inventor: YOUNG CALEB HOPKINS
IPC: B29C35/08
Filed: 2020-06-18
Abstract: A technical solution for determining and applying a correction layer to a three dimensional (3D) object undergoing a 3D printing process is described. The system can include an emitter device, a receiver device, and a 3D printer device. The emitter can illuminate a surface portion of an object, and a receiver device can receive a light input reflected from the surface portion of the object. The 3D printer device can create a profile for the surface portion of the object using an angle of incidence and an image received from the receiver device, and determine a difference between the profile and the specification of the object. The 3D printer device can generate instructions to apply a correction layer using the difference between the specification and the profile of the surface of the object.
Patent WO-2021007251-A1 (WO)
Title: Methane peak detection
Inventor: LANGLAND TODD
IPC: G01N1/02
Filed: 2020-07-07
Abstract: A method for monitoring air quality is described. The method includes measuring ethane and methane using a mobile sensor platform to provide sensor data. The sensor data includes methane data and ethane data captured at a nonzero mobile sensor platform speed. Methane and ethane peak(s) are identified in the sensor data. Correlation(s) between the methane and ethane peak(s) and/or between the methane peak(s) and at least one amount of  13 C are determined. A source for the methane is determined based on the correlation.
Patent WO-2021026293-A1 (WO)
Inventor: WANG YONGBAO
IPC: C12N9/16
Filed: 2020-08-06
Abstract: The invention provides compositions and methods for detecting a particular genetic polymorphism in a complex genomic environment. The present disclosure provides compositions and methods for genotyping a genetic variant located in a complex genomic environment, such as a genetic locus having multiple structural isoforms of a gene. The key advantages of the claimed methods are their reliance on the amplification of short DNA fragments involving only two sets of primers and do not require extensive sequencing step(s).
Patent WO-2021061355-A1 (WO)
Title: Impairment based physical layer fingerprint
Inventor: YUNUSOV DAVID
IPC: H04B7/08
Filed: 2020-09-01
Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a wireless device may receive a beamformed signal from a transmitting device. The wireless device may estimate a weighted sum based at least in part on one or more coefficients that relate to impairments associated with the transmitting device, a spatial location of the wireless device, and/or the like. The wireless device may determine a cryptographic key based at least in part on a ratio among the plurality of coefficients in the weighted sum, and one or more communications between the wireless device and the transmitting device may be secured based on the cryptographic key. Numerous other aspects are provided.
Patent WO-2021067302-A1 (WO)
Title: Ultrasonic probe
Inventor: BAKER CHARLES
IPC: A61B17/22
Filed: 2020-09-29
Abstract: A method of treating a calculi mass can include using an ultrasonic probe to produce acoustic energy and fragment the mass. The method can include varying the frequency at which fragmentation occurs to treat the mass with a resonant frequency. The ultrasonic probe can have a distal tip for contact with the mass, where the tip has a morphology for concentrating stress on the mass. The ultrasonic probe can have two or more ultrasonic horns to allow for higher voltage and power levels.